They played volleyball without a net at his Billionaire Bunker mansion.

DNA robots are emerging as tiny programmable machines that could one day deliver drugs, hunt viruses, and build molecular-scale devices. By borrowing ideas from traditional robotics and combining them ...

Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a catchall term that can carry stigma. The term “dementia” is an umbrella term ...

Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced a partnership with the Initiative ...

CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a precision tool, but is not perfect, and misplaced DNA edits can compromise ...

CAMBRIDGE, Mass. & NEW ORLEANS--(BUSINESS WIRE)--Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, ...

New findings highlight correlations between EEG and clinical outcome measures in Alzheimer’s disease Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive ...

An identical twin commits a crime and leaves their DNA at the scene. Can DNA testing reveal which twin is the culprit? This question reportedly came up in a case in France last month, in which the DNA ...

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...

Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. The ...

Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...